Exact Mass: 569.1620482000001
Exact Mass Matches: 569.1620482000001
Found 85 metabolites which its exact mass value is equals to given mass value 569.1620482000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Firsocostat
Emricasan
Guanosine, 2'-deoxy-N-(7,8,9,10-tetrahydro-7,8,9-trihydroxybenzo(a)pyren-10-yl)-
Astin C
Astin C (Asterin) is a cyclic pentapeptide with anticancer and anti-inflammatory properties[1]. Astin C (Asterin) is a cyclic pentapeptide with anticancer and anti-inflammatory properties[1]. Astin C (Asterin) is a cyclic pentapeptide with anticancer and anti-inflammatory properties[1].
C25H33Cl2N5O6_17,18-Dichloro-3,13-diethyl-6-(hydroxymethyl)-9-phenyldodecahydropyrrolo[1,2-d][1,4,7,10,13]pentaazacyclohexadecine-1,4,7,11,14(8H)-pentone
Cys Asp Phe Trp
Cys Asp Trp Phe
Cys Phe Asp Trp
Cys Phe Trp Asp
Cys Met Met Trp
Cys Met Trp Met
Cys Trp Asp Phe
Cys Trp Phe Asp
Cys Trp Met Met
Asp Cys Phe Trp
Asp Cys Trp Phe
Asp Phe Cys Trp
Asp Phe Trp Cys
Asp Trp Cys Phe
Asp Trp Phe Cys
Phe Cys Asp Trp
Phe Cys Trp Asp
Phe Asp Cys Trp
Phe Asp Trp Cys
Phe Trp Cys Asp
Phe Trp Asp Cys
Met Cys Met Trp
Met Cys Trp Met
Met Met Cys Trp
Met Met Trp Cys
Met Trp Cys Met
Met Trp Met Cys
Trp Cys Asp Phe
Trp Cys Phe Asp
Trp Cys Met Met
Trp Asp Cys Phe
Trp Asp Phe Cys
Trp Phe Cys Asp
Trp Phe Asp Cys
Trp Met Cys Met
Trp Met Met Cys
Emricasan
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2,3,5-Tri-O-benzyl-D-arabinofuranose 1-(4-nitrobenzoate)
Motesanib diphosphate
C22H29N5O9P2 (569.1440444000001)
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
Bosentan hydrate
D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D065128 - Endothelin Receptor Antagonists C28313 - Endothelin Receptor Antagonist Bosentan hydrate is a competitive and dual antagonist of endothelin-1 (ET) for the ETA and ETB receptors with Ki of 4.7 nM and 95 nM in human SMC, respectively.
2,3,5-TRI-O-BENZYL-1-O-(4-NITROBENZOYL)-D-ALPHA-ARABINOFURANOSE
Haloperidol-1-hydroxy-2-D-glucuronide
C27H33ClFNO9 (569.1827770000001)
3(2H)-Benzoxazolepropanesulfonic acid, 2-[4-(1,3-dibutyltetrahydro-4,6-dioxo-2-thioxo-5(2H)-pyrimidinylidene)-2-butenylidene]-, sodium salt
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes D003879 - Dermatologic Agents
Enasidenib Mesylate
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C137826 - Isocitrate Dehydrogenase Inhibitor > C168619 - IDH2 inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent Enasidenib mesylate is a first-in-class, oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes.
Firsocostat
D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor Firsocostat (ND-630; GS-0976; NDI-010976) is an acetyl-CoA carboxylase (ACC) inhibitor; inhibits human ACC1 and ACC2 with IC50 values of 2.1 and 6.1 nM, respectively.
Lactonamycin
C28H27NO12 (569.1533182000001)
An organic heterohexacyclic compound isolated from the culture broth of Streptomyces rishiriensis. It is an antibiotic with antibacterial activity.
{3-[(6-(anilinocarbonyl)-5-(4-ethoxyphenyl)-7-methyl-3-oxo-5H-[1,3]thiazolo[3,2-a]pyrimidin-2(3H)-ylidene)methyl]phenoxy}acetic acid
C31H27N3O6S (569.1620482000001)
(4-fluorophenyl)-[(1R)-1-(hydroxymethyl)-7-methoxy-1-thiophen-2-ylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanone
(4-fluorophenyl)-[(1S)-1-(hydroxymethyl)-7-methoxy-1-thiophen-2-ylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanone
(2r)-1',5,8,9,9',10-hexahydroxy-7-methoxy-3'-[(1e,3e)-penta-1,3-dien-1-yl]-6',7'-dihydrospiro[anthracene-2,8'-cyclopenta[g]isoquinoline]-1,3,4-trione
2,9-dihydroxy-15-[(5-hydroxy-6-methyloxan-2-yl)oxy]-18-methoxy-6-methyl-17,21-dioxa-6-azahexacyclo[11.10.0.0³,¹¹.0⁴,⁸.0¹⁵,²².0¹⁸,²²]tricosa-1,3,8,10,12-pentaene-7,14,20,23-tetrone
C28H27NO12 (569.1533182000001)
(3s,6s,9r,13s,17r,18s,18ar)-17,18-dichloro-3,13-diethyl-1,4,7,11-tetrahydroxy-6-(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one
1',5,8,9,9',10-hexahydroxy-7-methoxy-3'-(penta-1,3-dien-1-yl)-6',7'-dihydrospiro[anthracene-2,8'-cyclopenta[g]isoquinoline]-1,3,4-trione
(3r,6r,13r,17s,18r,18as)-17,18-dichloro-3,13-diethyl-1,4,7,11-tetrahydroxy-6-(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one
n-(6-{[(1s,3s)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1h-tetracen-1-yl]oxy}-3-hydroxy-2-methyloxan-4-yl)ethanimidic acid
(4s,5s,6s)-4,5-dihydroxy-n-[(3s)-2-hydroxy-4,5,6,7-tetrahydro-3h-azepin-3-yl]-6-[(r)-[(2s,3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-3-methoxyoxolan-2-yl](c-hydroxycarbonimidoyl)methoxy]-5,6-dihydro-4h-pyran-2-carboximidic acid
(4s,5s,6s)-6-[(r)-[(2s,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl](c-hydroxycarbonimidoyl)methoxy]-4,5-dihydroxy-n-[(3s,7r)-2-hydroxy-7-methyl-4,5,6,7-tetrahydro-3h-azepin-3-yl]-5,6-dihydro-4h-pyran-2-carboximidic acid
17,18-dichloro-3,13-diethyl-1,4,7,11-tetrahydroxy-6-(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one
(15s,18s)-2,9-dihydroxy-15-{[(2s,5s,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-18-methoxy-6-methyl-17,21-dioxa-6-azahexacyclo[11.10.0.0³,¹¹.0⁴,⁸.0¹⁵,²².0¹⁸,²²]tricosa-1,3,8,10,12-pentaene-7,14,20,23-tetrone
C28H27NO12 (569.1533182000001)